Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Current Leases: 2019-2024

Historic Current Leases for OptimizeRx (OPRX) over the last 6 years, with FY2024 value amounting to $168000.0.

  • OptimizeRx's Current Leases rose 615.38% to $207000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $207000.0, marking a year-over-year increase of 615.38%. This contributed to the annual value of $168000.0 for FY2024, which is 2432.43% down from last year.
  • Latest data reveals that OptimizeRx reported Current Leases of $168000.0 as of FY2024, which was down 2432.43% from $222000.0 recorded in FY2023.
  • OptimizeRx's 5-year Current Leases high stood at $222000.0 for FY2023, and its period low was $89902.0 during FY2022.
  • Moreover, its 5-year median value for Current Leases was $123220.0 (2020), whereas its average is $138820.8.
  • As far as peak fluctuations go, OptimizeRx's Current Leases tumbled by 2616.3% in 2021, and later skyrocketed by 14693.56% in 2023.
  • Annual analysis of 5 years shows OptimizeRx's Current Leases stood at $123220.0 in 2020, then decreased by 26.16% to $90982.0 in 2021, then dropped by 1.19% to $89902.0 in 2022, then skyrocketed by 146.94% to $222000.0 in 2023, then fell by 24.32% to $168000.0 in 2024.
  • Its Current Leases stands at $168000.0 for FY2024, versus $222000.0 for FY2023 and $89902.0 for FY2022.